Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

FSB will get access to Qiwi customer data online

2/14/23 QIWI

Fidelity Investments increased its stake in Yandex

2/14/23 YNDX

Yandex is testing a cab service in Namibia and Mozambique

2/13/23 YNDX

Tinkoff Bank registers the logo without the unicorn and the sword hand from the coat of arms of the Tinkoff family of nobles

2/13/23 T

Irkut will open a center for SSJ100 and MS-21 maintenance at Sheremetyevo in 2026-27

2/13/23 IRKT

Court Terminated Yandex's Lawsuit against Electronics Distributor A&DD

2/13/23 YNDX

Ozon is closing its car showcase

2/13/23 OZON

RusHydro launches 20% of electric filling stations in Russia in 2022

2/10/23 HYDR

Nornickel extended contracts for 2023 without special discounts

2/10/23 GMKN

Nornickel reported according to IFRS for 2022

2/10/23 GMKN